Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 14.3B | 15.0B | 24.1B | 15.2B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 614M | -836M | 2.6B | 684M |
Other operating expenses | -536M | 1.9B | 1.7B | 573M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | 33.7B | 20.6B |
Other income expense | 176M | 416M | 138M | 273M |
Pretax income | 6.0B | 4.9B | 11.4B | 6.8B |
Tax provision | 91M | -690M | 1.8B | 644M |
Net income | 5.9B | 5.6B | 9.6B | 6.1B |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | -1M | -1M | -1M | -1M |
Preferred stock dividends | — | — | — | — |